China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ: SXTC · Real-Time Price · USD
0.479
-0.051 (-9.64%)
At close: Nov 4, 2024, 4:00 PM
0.488
+0.009 (1.90%)
After-hours: Nov 4, 2024, 7:49 PM EST

China SXT Pharmaceuticals Statistics

Total Valuation

SXTC has a market cap or net worth of $1.66 million. The enterprise value is -$6.71 million.

Market Cap 1.66M
Enterprise Value -6.71M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

SXTC has 3.48 million shares outstanding. The number of shares has increased by 224.91% in one year.

Shares Outstanding 3.48M
Shares Change (YoY) +224.91%
Shares Change (QoQ) +145.95%
Owned by Insiders (%) 11.80%
Owned by Institutions (%) 2.54%
Float 3.07M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.22
Forward PS n/a
PB Ratio 0.08
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.60, with a Debt / Equity ratio of 0.27.

Current Ratio 1.60
Quick Ratio 1.51
Debt / Equity 0.27
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -3.78

Financial Efficiency

Return on equity (ROE) is -21.65% and return on invested capital (ROIC) is -6.34%.

Return on Equity (ROE) -21.65%
Return on Assets (ROA) -4.96%
Return on Capital (ROIC) -6.34%
Revenue Per Employee $25,713
Profits Per Employee -$41,314
Employee Count 75
Asset Turnover 0.07
Inventory Turnover 1.98

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) 1.16
52-Week Price Change n/a
50-Day Moving Average 0.64
200-Day Moving Average n/a
Relative Strength Index (RSI) 34.65
Average Volume (20 Days) 353,986

Short Selling Information

Short Interest 196,013
Short Previous Month 251,562
Short % of Shares Out 5.87%
Short % of Float n/a
Short Ratio (days to cover) 0.29

Income Statement

In the last 12 months, SXTC had revenue of $1.93 million and -$3.10 million in losses. Loss per share was -$3.57.

Revenue 1.93M
Gross Profit 553,971
Operating Income -2.09M
Pretax Income -14.14M
Net Income -3.10M
EBITDA -1.89M
EBIT -2.09M
Loss Per Share -$3.57
Full Income Statement

Balance Sheet

The company has $12.07 million in cash and $3.70 million in debt, giving a net cash position of $8.38 million or $2.41 per share.

Cash & Cash Equivalents 12.07M
Total Debt 3.70M
Net Cash 8.38M
Net Cash Per Share $2.41
Equity (Book Value) 13.93M
Book Value Per Share 6.28
Working Capital 5.33M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$1.93 million and capital expenditures -$7,063, giving a free cash flow of -$1.94 million.

Operating Cash Flow -1.93M
Capital Expenditures -7,063
Free Cash Flow -1.94M
FCF Per Share -$0.56
Full Cash Flow Statement

Margins

Gross margin is 28.73%, with operating and profit margins of -108.49% and -160.67%.

Gross Margin 28.73%
Operating Margin -108.49%
Pretax Margin -160.67%
Profit Margin -160.67%
EBITDA Margin -97.95%
EBIT Margin -108.49%
FCF Margin -540.69%

Dividends & Yields

SXTC does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -224.91%
Shareholder Yield -224.91%
Earnings Yield -186.13%
FCF Yield -116.24%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

The last stock split was on October 5, 2023. It was a reverse split with a ratio of 0.04:1.

Last Split Date Oct 5, 2023
Split Type Reverse
Split Ratio 0.04:1

Scores

SXTC has an Altman Z-Score of -1.32 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -1.32
Piotroski F-Score 5